zoledronic acid has been researched along with DiGeorge Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barna, G; Çakır, U; Érsek, B; Faqi, S; Gyöngy, M; Hajdara, A; Kárpáti, S; Mayer, B; Németh, K; Silló, P; Széky, B | 1 |
1 other study(ies) available for zoledronic acid and DiGeorge Syndrome
| Article | Year |
|---|---|
Targeting Melanoma-Associated Fibroblasts (MAFs) with Activated γδ (Vδ2) T Cells: An In Vitro Cytotoxicity Model.
Topics: Cancer-Associated Fibroblasts; DiGeorge Syndrome; Fibroblasts; Humans; Melanoma; Tumor Microenvironment; Zoledronic Acid | 2023 |